Development of methodology for prioritisation in cancer screening/prevention

Summary

This task will entail activities organised within the following
subtasks:
4.4.1 Situation analysis of prioritisation in cancer screening.
4.4.2 Development of a framework for prioritisation of cancer screening programs.
4.4.3 Pilot testing of prioritisation framework in exemplary countries to assess the feasibility, acceptability and comprehensibility of the prioritisation framework.
4.4.4 Validation and transferability of the MAS-AI tool for AI assessment in healthcare and expansion of the tool to novel screening based on the EUnetHTA core model, specifically to evaluate AI interventions.
This task will be led by EMC, Netherlands, co-led by CPO Turin, Italy; CSF, Finland; and RSYD, Denmark.

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen VerticalThe general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο